Page 27 - Pharma

Core Diagnostics partners with US-based Paradigm for tumour profiling in India

Through this alliance Core Diagnostics will offer Paradigm's most advanced cancer profiling services in India that will help improve treatment mechanisms

Suven Life bags product patents for NCEs in Australia, Eurasia, Israel and US

The patents have been granted to the company's new chemical entities (NCEs) for CNS therapy through mechanism of action - H3 inverse agonist

Ajanta Pharma receives US FDA nod for migraine drug zolmitriptan

Zolmitriptan tablet is a generic version of Zomig, a registered trademark of AstraZeneca

Workers of GSK Consumer Healthcare's Nabha plant go on strike

The company decides to suspend operations temporarily

India and Japan to seek regulatory collaboration for medical products

The Japan has extended support to Government of India for Indian regulators' skill enhancement through its Asia Training Centre

Got promoted? Here are a few things to keep in mind

Promotions inherently entail change, new responsibilities and different career challenges. Hence, it is important to ask a few specific questions before you take up the new role, says Abhijit Nimgaonk

Govt to launch a hub & spoke model to set up science cities and science centres

The Science & Technology Ministry working on 'five year rolling plan' to measure plans & their implementation

Pharma exports to witness a sharp fall as value of off-patent drugs declines

While the exports witnessed growth of 19 percent in the last decade, it is expected to decline sharply to 10-12 percent annually over the next 5 years, says a Crisil Research report

Jubilant and Cyclopharm terminate licensing agreement for Technegas

Both companies to discuss potential commercial opportunities once Cyclopharm obtains US FDA approval for Technegas

India and WHO inks pact for promotion of traditional medicines

The agreement will help implementation of the 'WHO Traditional and Complementary Medicine Strategy: 2014-2023' and global promotion of traditional Indian systems of medicine

How big data is changing the face of healthcare

Today big data analytics is being used to revolutionise healthcare, improve delivery, systematise research and achieve better diagnosis, says Dr Sanjiv Aggarwal

Kokilaben Hospital joins 'Go Green Stay Fit' campaign

The campaign, initiated in January this year by the Forum for Injection Technique (FIT), promotes the best practices in diabetes management and safe disposal of medical waste

Strides Shasun to divest UK arm for Rs 240 crore

Shasun Pharma Solutions Ltd (SPSL), which is into CRAMS API business, will be bought by the current management team of SPSL

Strides Shasun's Australian arm inks supply pact with Pharmacy Alliance

The new agreement also includes investment by Arrow Pharmaceuticals, Strides Shasun's Australian subsidiary, in Pharmacy Alliance's plans for growth and retail innovation

Aurobindo Pharma receives US FDA nod for hydromorphone tablet

Hydromorphone hydrochloride tablet, used to relieve moderate to severe pain, has an estimated market size of $ 50 mn for the twelve months ending March 2016, according to IMS

Mylan acquires Renaissance's dermatology biz for $ 1 bn

With this acquisition, the company will have critical mass in the dermatology/topicals area and catapult to a leading position in this space, says Rajiv Malik, president, Mylan

Pfizer to buy biopharma firm Anacor for $ 5.2 bn

Anacor will be a strong fit with Pfizer's innovative business, further supporting its strategic focus on inflammation and immunology

Companies have to take proactive steps to optimise water usage: Sudhir Shenoy

In this interview, Sudhir Shenoy, country manager, Dow India, discusses water crisis facing the manufacturing sector and probable solution to mitigate this challenges

Piramal Enterprises strengthens OTC portfolio with Pfizer's four brands

The company to acquire Pfizer's four brands - Ferradol, Neko, Sloan's and Waterbury's Compound - for Rs 110 cr

Industry bodies welcome new IPR policy

As per the policy, DIPP will be the nodal department for all IPR related developments in India